TOP TIERMARKET NEWSWIRE
SEC Form 4 history

ULTRAGENYX PHARMACEU (RARE) insider trades

ULTRAGENYX PHARMACEU (RARE) insider trading activity (SEC Form 4). Over the trailing 90 days, RARE insiders filed 0 purchases totalling $0 and 5 sales totalling $340K — net SELLING of $340K. Most recent filing: Sep 15, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
5
$340K
Net (90d)
-$340K
net selling
Most recent
Sep 15, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 15, 2026Huizenga Theodore AlanSVP, Chief Accounting OfficerS Sale—$13.57$17Kfiling
Sep 8, 2026Huizenga Theodore AlanSVP, Chief Accounting OfficerS Sale—$13.99$2Kfiling
Aug 4, 2026Horn HowardCFOS Sale—$24.92$117Kfiling
Aug 4, 2026Parschauer Karah HerdmanEVP, GCS Sale—$24.92$47Kfiling
Jul 6, 2026Horn HowardCFOS Sale—$33.13$156Kfiling
Jun 15, 2026Sanders Corazon (Corsee) D.DirS Sale—$25.05$50Kfiling
Jun 15, 2026Parschauer Karah HerdmanEVP, GCS Sale—$24.62$47Kfiling
Jun 1, 2026Horn HowardCFOS Sale—$23.77$111Kfiling
May 18, 2026Suliman ShehnaazDirS SaleOE—$25.12$144Kfiling